Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

Jan. 13, 1999

Key proteomics patents issued to Oxford GlycoSciences

Jan. 13, 1999

Isolex 300 and 300i cell selection system is approvable, FDA says

Jan. 12, 1999

Incyte announces new database agreement with P&U

Jan. 11, 1999

Genelabs and DuPont renew collaboration on novel compounds that regulate gene expression

Jan. 8, 1999

New family of gene-regulating enzymes discovered by Signal, Hebrew University

Jan. 7, 1999

U.S. patent issued to Millennium covers novel forms of caspase 8

Jan. 7, 1999

Sugen awarded U.S. patent for transcript imaging technology

Jan. 7, 1999

Telomerase expression extends lifespan of normal human cells without oncogenic transformation

Jan. 4, 1999

Modified TAPET organisms with tumor-targeting properties but reduced virulence and side effects

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...